Sabaa International Company for Pharmaceutical and Chemical Industry (EGX:SIPC)

Market Cap	907.50M +140.4%
Revenue (ttm)	46.52M +41.4%
Net Income	2.13M
EPS	0.01
Shares Out	250.00M
PE Ratio	426.54
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,303,556
Open	3.490
Previous Close	3.490
Day's Range	3.470 - 3.660
52-Week Range	2.300 - 4.900
Beta	0.50
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 16, 2026

About EGX:SIPC

Sabaa International Company for Pharmaceutical and Chemical Industry operates as a healthcare company in Egypt. It provides hard gelatin capsules, such as Acitretin; film coated tablets, including Saboctic, Topiramate, and Tolterodine; and tablets comprising Claudol and Flamogen E.C.T. The company also offers generics, OTCs, food supplements, and veterinary products, as well as medicine trials services. The company was founded in 2000 and is based in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 2000
• Employees: 165
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: SIPC

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 15, 2026

Data Sources Report a data error